Table 2

Association between subgroups of recreational substances and premature ASCVD

Recreational substancesPatients with premature ASCVD
(n=135 703)
n (%)
Patients with non-premature ASCVD
(n=1 112 455)
n (%)
P value*Partially adjusted
OR (95% CI)
†Fully adjusted OR (95% CI)
Tobacco use85 329 (62.9%)452 122 (40.6%)<0.012.44 (2.42 to 2.48)1.97 (1.94 to 2.00)
Alcohol use43 159 (31.8%)164 714 (14.8%)<0.012.57 (2.54 to 2.61)1.50 (1.47 to 1.52)
Illicit drug use27 576 (20.3%)53 045 (4.8%)<0.014.51 (4.44 to 4.60)2.87 (2.81 to 2.93)
Cocaine use16 335 (12.9%)27 415 (2.5%)<0.014.37 (4.27 to 4.47)2.44 (2.38 to 2.50)
Amphetamine use3897 (2.9%)5802 (0.5%)<0.014.88 (4.67 to 5.10)2.74 (2.62 to 2.87)
Cannabis use17 014 (12.5%)30 055 (2.7%)<0.014.45 (4.36 to 4.55)2.65 (2.59 to 2.71)
Other drugs/unspecified17 608 (13.0%)30 941 (2.8%)<0.014.40 (4.30 to 4.49)2.53 (2.47 to 2.59)
  • *Partially adjusted model: adjusted for patient’s gender, race, obesity, hypertension, diabetes mellitus, hypercholesterolaemia, presence of ischaemic heart disease and Diagnostic Cost Group Relative Risk Score (marker of patient’s overall illness burden).

  • †Fully adjusted model: adjusted for variables in the partially adjusted model and in addition adjusted for two other categories of drug use (eg, tobacco use regression model was adjusted for concomitant alcohol abuse and illicit drug use).

  • ASCVD, atherosclerotic cardiovascular disease.